Cardiac Medical Therapy encompasses a spectrum of pharmaceutical interventions designed to manage and treat various heart-related conditions. These therapeutic measures involve administering medications tailored to address specific aspects of cardiovascular health, aiming to optimise function and alleviate symptoms.
Angioplasty, or Percutaneous Transluminal Coronary Angioplasty (PTCA) or balloon angioplasty, is a medical procedure designed to treat narrowed or blocked blood vessels, particularly coronary arteries. During angioplasty, a balloon-tipped catheter is guided to the affected area and inflated, compressing the plaque against the artery walls and restoring blood flow.
Arrhythmia is an abnormal heart rhythm that may manifest as irregular heartbeats, too fast (tachycardia), too slow (bradycardia), or an irregular combination of both. This condition disrupts the heart’s natural electrical impulses, affecting its ability to pump blood efficiently. Arrhythmias can occur in the heart’s atria (upper chambers) or ventricles (lower chambers) and can be a temporary or chronic condition.
The heart, a vital organ for pumping blood throughout the body, is susceptible to various conditions that can compromise its function. Cardiovascular diseases, including arrhythmias, heart failure, and bradycardia, pose significant threats to heart health. These conditions often necessitate innovative and modern treatment approaches to enhance affected individuals’ quality and longevity of life.
Cardiac Rehabilitation (CR) is a comprehensive and multidisciplinary program designed to enhance the cardiovascular health of individuals who have experienced heart-related issues. It encompasses a range of medical, physical, and lifestyle interventions to improve the overall well-being of patients recovering from cardiac events or surgeries.
